Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Titanium dioxide + bisoctrizole is a fixed-dose combination used primarily in topical sunscreen formulations for broad-spectrum ultraviolet (UV) protection. Titanium dioxide is an inorganic compound that acts as a physical UV filter by reflecting and scattering UVA and UVB rays. Bisoctrizole, also known as methylene bis-benzotriazolyl tetramethylbutylphenol, is an organic benzotriazole-based compound that absorbs, reflects, and scatters both UVA and UVB radiation. Bisoctrizole functions as a hybrid sun-blocking agent with both chemical (absorption) and physical (reflection/scattering) properties. The combination provides enhanced photoprotection for the skin against harmful effects of solar radiation. This combination has been developed for use in sunscreens and other dermatological products to prevent sunburn, photoaging, and related skin disorders[1][2][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on titanium dioxide + bisoctrizole.